{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:10:09Z","timestamp":1789017009460,"version":"build-2803163510"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Acute liver failure (ALF) is a rapidly progressive and life-threatening syndrome with high short-term mortality. The prognostic value of early longitudinal changes in peripheral immune cell counts remains unclear. This study investigated whether early dynamic changes in peripheral monocytes (MONO) are associated with 28-day mortality in ALF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this single-center retrospective longitudinal cohort study, 266 patients with International Classification of Diseases-coded ALF between October 2018 and January 2026 were screened. After chart review and application of predefined diagnostic criteria, 46 patients were included. Peripheral blood cell parameters within 7 days after admission were analyzed. MONO-derived indices included delta MONO and slope MONO. Linear mixed-effects models assessed MONO trajectories. Additional analyses included clustering, logistic regression, and model evaluation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 46 patients, 23 (50.0%) died within 28 days, while the remaining 23 patients survived. Baseline MONO did not differ between groups. MONO trajectories showed a stable pattern in survivors and a progressive increase in non-survivors, with significant time\u2009\u00d7\u2009group interaction after adjustment for age, gender, and white blood cells. Higher delta MONO and slope MONO were observed in non-survivors. Trajectory-based clustering identified an increasing-MONO phenotype associated with higher mortality. In multivariable analyses, delta MONO showed the most consistent association with 28-day mortality, whereas baseline MONO showed model-dependent associations and slope MONO was less stable after covariate adjustment. Exploratory prognostic analyses suggested that MONO dynamics may provide complementary information beyond conventional variables. A shorter-window analysis further showed that MONO trajectory divergence was already detectable within the first 72\u2005h after admission.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Early increases in peripheral MONO are associated with 28-day mortality in ALF, with delta MONO showing the most consistent association across multivariable analyses. Longitudinal MONO monitoring may provide complementary information beyond single baseline measurements, although these findings require validation in larger cohorts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1945730","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:32:03Z","timestamp":1789014723000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Early peripheral monocyte dynamics are associated with 28-day mortality in acute liver failure: an exploratory longitudinal cohort study"],"prefix":"10.3389","volume":"13","author":[{"given":"Bin","family":"Niu","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, The First Hospital of Shanxi Medical University","place":["Taiyuan, China"]},{"name":"The First Clinical Medical School, Shanxi Medical University","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The First Hospital of Shanxi Medical University","place":["Taiyuan, China"]},{"name":"The First Clinical Medical School, Shanxi Medical University","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinran","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The First Hospital of Shanxi Medical University","place":["Taiyuan, China"]},{"name":"The First Clinical Medical School, Shanxi Medical University","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The First Hospital of Shanxi Medical University","place":["Taiyuan, China"]},{"name":"The First Clinical Medical School, Shanxi Medical University","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangdi","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The First Hospital of Shanxi Medical University","place":["Taiyuan, China"]},{"name":"The First Clinical Medical School, Shanxi Medical University","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiongjie","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The First Hospital of Shanxi Medical University","place":["Taiyuan, China"]},{"name":"The First Clinical Medical School, Shanxi Medical University","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liaoyun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, The First Hospital of Shanxi Medical University","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/S0140-6736(24)00693-7","article-title":"Acute liver failure","volume":"404","author":"Maiwall","year":"2024","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/S2468-1253(23)00142-5","article-title":"Acute liver failure in low-income and middle-income countries","volume":"8","author":"Vento","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.cgh.2015.10.007","article-title":"Ability of King\u2019s college criteria and model for end-stage liver disease scores to predict mortality of patients with acute liver failure: a meta-analysis","volume":"14","author":"McPhail","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"101959","DOI":"10.1016\/j.bpg.2024.101959","article-title":"Definitions, etiopathogenesis and epidemiology of ALF","volume":"73","author":"Biswas","year":"2024","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"586","DOI":"10.4254\/wjh.v11.i7.586","article-title":"Epidemiology and outcomes of acute liver failure in Australia","volume":"11","author":"Hey","year":"2019","journal-title":"World J Hepatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.3389\/fimmu.2020.02013","article-title":"Abnormal innate immunity in acute-on-chronic liver failure: immunotargets for therapeutics","volume":"11","author":"Khanam","year":"2020","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"9522","DOI":"10.3390\/ijms25179522","article-title":"The impact of liver failure on the immune system","volume":"25","author":"D\u0105browska","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3760\/cma.j.cn501113-20241206-00614","article-title":"Guidelines for the diagnosis and treatment of liver failure (2024 version)","volume":"33","year":"2025","journal-title":"Chin J Hepatol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/BF03656390","article-title":"Ratio of neutrophil to lymphocyte counts\u2013rapid and simple parameter of systemic inflammation and stress in critically ill","volume":"102","author":"Zahorec","year":"2001","journal-title":"Bratisl Lek Listy"},{"key":"B10","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1097\/DCR.0000000000002291","article-title":"Prognostic significance of lymphocyte-to-monocyte and platelet-to-lymphocyte ratio in rectal cancer: a systematic review, meta-analysis, and meta-regression","volume":"65","author":"Hamid","year":"2022","journal-title":"Dis Colon Rectum"},{"key":"B11","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3109\/1354750X.2012.656705","article-title":"Clinical significance of preoperative neutrophil-lymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer","volume":"17","author":"Kwon","year":"2012","journal-title":"Biomarkers"},{"key":"B12","doi-asserted-by":"publisher","first-page":"6212","DOI":"10.1158\/1078-0432.CCR-14-0442","article-title":"Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma","volume":"20","author":"Hu","year":"2014","journal-title":"Clin Cancer Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1002\/cncr.30057","article-title":"A novel systemic inflammation response index (SIRI) for predicting the survival of patients with pancreatic cancer after chemotherapy","volume":"122","author":"Qi","year":"2016","journal-title":"Cancer"},{"key":"B14","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/0016-5085(89)90081-4","article-title":"Early indicators of prognosis in fulminant hepatic failure","volume":"97","author":"O\u2019Grady","year":"1989","journal-title":"Gastroenterology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A model to predict survival in patients with end-stage liver disease","volume":"33","author":"Kamath","year":"2001","journal-title":"Hepatology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1053\/j.gastro.2006.02.010","article-title":"Evidence-based incorporation of serum sodium concentration into MELD","volume":"130","author":"Biggins","year":"2006","journal-title":"Gastroenterology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.14309\/ajg.0000000000002340","article-title":"Acute liver failure guidelines","volume":"118","author":"Shingina","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"B18","article-title":"Acute liver failure","volume-title":"StatPearls","author":"Girish","year":"2025"},{"key":"B19","doi-asserted-by":"publisher","first-page":"101131","DOI":"10.1016\/j.jhepr.2024.101131","article-title":"Acute liver failure: a practical update","volume":"6","author":"Fern\u00e1ndez","year":"2024","journal-title":"JHEP Rep"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.jhep.2016.12.003","article-title":"EASL Clinical practical guidelines on the management of acute (fulminant) liver failure","volume":"66","author":"Wendon","year":"2017","journal-title":"J Hepatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1055\/s-0042-1755274","article-title":"Management of acute liver failure: update 2022","volume":"42","author":"Tujios","year":"2022","journal-title":"Semin Liver Dis"},{"key":"B22","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.jare.2025.06.019","article-title":"Multi-algorithm consensus classification identifies three distinct acute liver failure subtypes with differential treatment responses: a multi-database cohort study","volume":"82","author":"Yang","year":"2026","journal-title":"J Adv Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.jhep.2008.08.009","article-title":"The importance of immune dysfunction in determining outcome in acute liver failure","volume":"49","author":"Antoniades","year":"2008","journal-title":"J Hepatol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/hep.21240","article-title":"Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in Acetaminophen-induced acute liver failure","volume":"44","author":"Antoniades","year":"2006","journal-title":"Hepatology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.3389\/fimmu.2018.02948","article-title":"The role of monocytes and macrophages in acute and acute-on-chronic liver failure","volume":"9","author":"Triantafyllou","year":"2018","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.jhep.2014.03.031","article-title":"Modulation of monocyte\/macrophage function: a therapeutic strategy in the treatment of acute liver failure","volume":"61","author":"Possamai","year":"2014","journal-title":"J Hepatol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1237042","DOI":"10.3389\/fimmu.2023.1237042","article-title":"The multifaceted role of macrophages during acute liver injury","volume":"14","author":"Hassan","year":"2023","journal-title":"Front Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/cmi.2015.104","article-title":"Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies","volume":"13","author":"Ju","year":"2016","journal-title":"Cell Mol Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"7249","DOI":"10.3390\/ijms22147249","article-title":"Liver injury and the macrophage issue: molecular and mechanistic facts and their clinical relevance","volume":"22","author":"Roohani","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.3748\/wjg.v16.i15.1811","article-title":"Role of monocytes and macrophages in experimental and human acute liver failure","volume":"16","author":"Possamai","year":"2010","journal-title":"World J Gastroenterol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1002\/hep.26933","article-title":"Secretory leukocyte protease inhibitor: a pivotal mediator of anti-inflammatory responses in Acetaminophen-induced acute liver failure","volume":"59","author":"Antoniades","year":"2014","journal-title":"Hepatology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1056\/NEJMra1208623","article-title":"Severe sepsis and septic shock","volume":"369","author":"Angus","year":"2013","journal-title":"N Engl J Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1002\/hep.28682","article-title":"Chemokine (C-C motif) receptor 2-positive monocytes aggravate the early phase of Acetaminophen-induced acute liver injury","volume":"64","author":"Mossanen","year":"2016","journal-title":"Hepatology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.3748\/wjg.v26.i16.1879","article-title":"Regulation of macrophage activation in the liver after acute injury: role of the fibrinolytic system","volume":"26","author":"Roth","year":"2020","journal-title":"World J Gastroenterol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1097\/HEP.0000000000000458","article-title":"Future directions in acute liver failure","volume":"78","author":"Stravitz","year":"2023","journal-title":"Hepatology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"101956","DOI":"10.1016\/j.bpg.2024.101956","article-title":"Coagulopathy in acute liver failure","volume":"73","author":"Roy","year":"2024","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.jhep.2007.05.014","article-title":"Soluble CD163 from activated macrophages predicts mortality in acute liver failure","volume":"47","author":"M\u00f8ller","year":"2007","journal-title":"J Hepatol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1111\/liv.15928","article-title":"Macrophage activation markers are associated with infection and mortality in patients with acute liver failure","volume":"44","author":"Cavazza","year":"2024","journal-title":"Liver Int"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1596134","DOI":"10.3389\/fmed.2025.1596134","article-title":"Early dynamic changes in platelet counts and 28-day mortality in sepsis patients: a retrospective cohort study using dynamic latent class model and generalized additive mixture model analysis","volume":"12","author":"Han","year":"2025","journal-title":"Front Med"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1945730\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:32:17Z","timestamp":1789014737000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1945730\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":40,"alternative-id":["10.3389\/fmed.2026.1945730"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1945730","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"article-number":"1945730"}}